European Archives - Page 478 of 1613 - European Medical Journal

Syphilis and Drug-Resistant Gonorrhoea on the Rise

The UKHSA has released its annual STI data, with continuing concern over rising syphilis and drug-resistant gonorrhoea.

Global Rise in Skin Cancer Among Older Adults

A new global observational study has revealed a continued rise in skin cancer burden among older populations, particularly in high-income countries.

Radiotherapy After Prostate Surgery Causes Minimal Side Effects

This clinical trial evaluated the safety of stereotactic body radiotherapy to the prostate bed following radical prostatectomy.

PET/CT Refines Biopsy Strategy for Suspected Lung Cancer

New findings support the integration of PET/CT prior to biopsy in patients with intermediate-to-high-risk lung nodules.

Breast MRI Efficiency Boosted by AI Without Compromising Diagnosis

AI-guided breast MRI could halve scan times without missing cancers, offering new efficiency for screening programmes.

One-Third of Patients with Myeloma May Achieve Long-Term Survival

A new analysis of early total therapy clinical trials has revealed that up to one-third of patients with newly diagnosed multiple myeloma may achieve long-term survival.

ERA 2025: Immune Profiling of Checkpoint Inhibitor-Induced Nephritis Reveals Distinct Subtypes with Prognostic Value

Presented at ERA 2025, this multicentre study identifies three immune subtypes of checkpoint inhibitor–induced nephritis, linking them to clinical outcomes and treatment responses.

Nasal Test Enhances Allergy Diagnosis Accuracy

This study investigates the role of the intranasal Schirmer test as a supportive or alternative tool to anterior rhinomanometry for allergic rhinitis.

Progesterone-Only Pill Linked to Higher Asthma Risk in Young Women

Progestogen-only contraceptives may raise the risk of asthma attacks in younger women and those with eosinophilic asthma, according to a new population-based cohort study.

National Study Reveals Gaps in Paediatric Hepatitis C Treatment

These figures indicate a substantial drop-off following diagnosis, undermining efforts to eliminate HCV in paediatric populations.